Cargando…

Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies

BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies o...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowe, Francesca L., Appleby, Paul N., Travis, Ruth C., Barnett, Matt, Brasky, Theodore M., Bueno-de-Mesquita, H. Bas, Chajes, Veronique, Chavarro, Jorge E., Chirlaque, Maria-Dolores, English, Dallas R., Gibson, Robert A., Giles, Graham G., Goodman, Gary E., Henning, Susanne M., Kaaks, Rudolf, King, Irena B., Kolonel, Lawrence N., Kristal, Alan R., Neuhouser, Marian L., Park, Song-Yi, Severi, Gianluca, Siddiq, Afshan, Stampfer, Meir J., Stattin, Pär, Tangen, Catherine M., Tjønneland, Anne, Trichopoulos, Dimitrios, Tumino, Rosario, Wilkens, Lynne R., Key, Timothy J., Allen, Naomi E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188122/
https://www.ncbi.nlm.nih.gov/pubmed/25210201
http://dx.doi.org/10.1093/jnci/dju240
_version_ 1782338219482808320
author Crowe, Francesca L.
Appleby, Paul N.
Travis, Ruth C.
Barnett, Matt
Brasky, Theodore M.
Bueno-de-Mesquita, H. Bas
Chajes, Veronique
Chavarro, Jorge E.
Chirlaque, Maria-Dolores
English, Dallas R.
Gibson, Robert A.
Giles, Graham G.
Goodman, Gary E.
Henning, Susanne M.
Kaaks, Rudolf
King, Irena B.
Kolonel, Lawrence N.
Kristal, Alan R.
Neuhouser, Marian L.
Park, Song-Yi
Severi, Gianluca
Siddiq, Afshan
Stampfer, Meir J.
Stattin, Pär
Tangen, Catherine M.
Tjønneland, Anne
Trichopoulos, Dimitrios
Tumino, Rosario
Wilkens, Lynne R.
Key, Timothy J.
Allen, Naomi E.
author_facet Crowe, Francesca L.
Appleby, Paul N.
Travis, Ruth C.
Barnett, Matt
Brasky, Theodore M.
Bueno-de-Mesquita, H. Bas
Chajes, Veronique
Chavarro, Jorge E.
Chirlaque, Maria-Dolores
English, Dallas R.
Gibson, Robert A.
Giles, Graham G.
Goodman, Gary E.
Henning, Susanne M.
Kaaks, Rudolf
King, Irena B.
Kolonel, Lawrence N.
Kristal, Alan R.
Neuhouser, Marian L.
Park, Song-Yi
Severi, Gianluca
Siddiq, Afshan
Stampfer, Meir J.
Stattin, Pär
Tangen, Catherine M.
Tjønneland, Anne
Trichopoulos, Dimitrios
Tumino, Rosario
Wilkens, Lynne R.
Key, Timothy J.
Allen, Naomi E.
author_sort Crowe, Francesca L.
collection PubMed
description BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies on circulating fatty acids and prostate cancer were invited to collaborate. Investigators provided individual participant data on circulating fatty acids (weight percent) and other characteristics of prostate cancer cases and controls. Prostate cancer risk by study-specific fifths of 14 fatty acids was estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided. RESULTS: Five thousand and ninety-eight case patients and 6649 control patients from seven studies with an average follow-up of 5.1 (SD = 3.3) years were included. Stearic acid (18:0) was inversely associated with total prostate cancer (odds ratio [OR] Q5 vs Q1 = 0.88, 95% confidence interval [CI] = 0.78 to 1.00, P (trend) = .043). Prostate cancer risk was, respectively, 14% and 16% greater in the highest fifth of eicosapentaenoic acid (20:5n-3) (OR = 1.14, 95% CI = 1.01 to 1.29, P (trend) = .001) and docosapentaenoic acid (22:5n-3) (OR = 1.16, 95% CI = 1.02 to 1.33, P (trend) = .003), but in each case there was heterogeneity between studies (P = .022 and P < .001, respectively). There was heterogeneity in the association between docosapentaenoic acid and prostate cancer by grade of disease (P = .006); the association was statistically significant for low-grade disease but not high-grade disease. The remaining 11 fatty acids were not statistically associated with total prostate cancer risk. CONCLUSION: There was no strong evidence that circulating fatty acids are important predictors of prostate cancer risk. It is not clear whether the modest associations of stearic, eicosapentaenoic, and docosapentaenoic acid are causal.
format Online
Article
Text
id pubmed-4188122
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-41881222014-10-16 Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies Crowe, Francesca L. Appleby, Paul N. Travis, Ruth C. Barnett, Matt Brasky, Theodore M. Bueno-de-Mesquita, H. Bas Chajes, Veronique Chavarro, Jorge E. Chirlaque, Maria-Dolores English, Dallas R. Gibson, Robert A. Giles, Graham G. Goodman, Gary E. Henning, Susanne M. Kaaks, Rudolf King, Irena B. Kolonel, Lawrence N. Kristal, Alan R. Neuhouser, Marian L. Park, Song-Yi Severi, Gianluca Siddiq, Afshan Stampfer, Meir J. Stattin, Pär Tangen, Catherine M. Tjønneland, Anne Trichopoulos, Dimitrios Tumino, Rosario Wilkens, Lynne R. Key, Timothy J. Allen, Naomi E. J Natl Cancer Inst Review BACKGROUND: Individual studies have suggested that some circulating fatty acids are associated with prostate cancer risk, but have not been large enough to provide precise estimates of associations, particularly by stage and grade of disease. METHODS: Principal investigators of prospective studies on circulating fatty acids and prostate cancer were invited to collaborate. Investigators provided individual participant data on circulating fatty acids (weight percent) and other characteristics of prostate cancer cases and controls. Prostate cancer risk by study-specific fifths of 14 fatty acids was estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided. RESULTS: Five thousand and ninety-eight case patients and 6649 control patients from seven studies with an average follow-up of 5.1 (SD = 3.3) years were included. Stearic acid (18:0) was inversely associated with total prostate cancer (odds ratio [OR] Q5 vs Q1 = 0.88, 95% confidence interval [CI] = 0.78 to 1.00, P (trend) = .043). Prostate cancer risk was, respectively, 14% and 16% greater in the highest fifth of eicosapentaenoic acid (20:5n-3) (OR = 1.14, 95% CI = 1.01 to 1.29, P (trend) = .001) and docosapentaenoic acid (22:5n-3) (OR = 1.16, 95% CI = 1.02 to 1.33, P (trend) = .003), but in each case there was heterogeneity between studies (P = .022 and P < .001, respectively). There was heterogeneity in the association between docosapentaenoic acid and prostate cancer by grade of disease (P = .006); the association was statistically significant for low-grade disease but not high-grade disease. The remaining 11 fatty acids were not statistically associated with total prostate cancer risk. CONCLUSION: There was no strong evidence that circulating fatty acids are important predictors of prostate cancer risk. It is not clear whether the modest associations of stearic, eicosapentaenoic, and docosapentaenoic acid are causal. Oxford University Press 2014-09-04 /pmc/articles/PMC4188122/ /pubmed/25210201 http://dx.doi.org/10.1093/jnci/dju240 Text en © The Author 2014. Published by Oxford University Press. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Crowe, Francesca L.
Appleby, Paul N.
Travis, Ruth C.
Barnett, Matt
Brasky, Theodore M.
Bueno-de-Mesquita, H. Bas
Chajes, Veronique
Chavarro, Jorge E.
Chirlaque, Maria-Dolores
English, Dallas R.
Gibson, Robert A.
Giles, Graham G.
Goodman, Gary E.
Henning, Susanne M.
Kaaks, Rudolf
King, Irena B.
Kolonel, Lawrence N.
Kristal, Alan R.
Neuhouser, Marian L.
Park, Song-Yi
Severi, Gianluca
Siddiq, Afshan
Stampfer, Meir J.
Stattin, Pär
Tangen, Catherine M.
Tjønneland, Anne
Trichopoulos, Dimitrios
Tumino, Rosario
Wilkens, Lynne R.
Key, Timothy J.
Allen, Naomi E.
Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title_full Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title_fullStr Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title_full_unstemmed Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title_short Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies
title_sort circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188122/
https://www.ncbi.nlm.nih.gov/pubmed/25210201
http://dx.doi.org/10.1093/jnci/dju240
work_keys_str_mv AT crowefrancescal circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT applebypauln circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT travisruthc circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT barnettmatt circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT braskytheodorem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT buenodemesquitahbas circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT chajesveronique circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT chavarrojorgee circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT chirlaquemariadolores circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT englishdallasr circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT gibsonroberta circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT gilesgrahamg circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT goodmangarye circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT henningsusannem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT kaaksrudolf circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT kingirenab circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT kolonellawrencen circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT kristalalanr circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT neuhousermarianl circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT parksongyi circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT severigianluca circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT siddiqafshan circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT stampfermeirj circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT stattinpar circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT tangencatherinem circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT tjønnelandanne circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT trichopoulosdimitrios circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT tuminorosario circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT wilkenslynner circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT keytimothyj circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT allennaomie circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies
AT circulatingfattyacidsandprostatecancerriskindividualparticipantmetaanalysisofprospectivestudies